VALYSTR · Stock research
Listed on NasdaqCM. What the market is pricing into BioNexus Gene Lab Corp. (BGLC) in the Materials sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Materials · Specialty Chemicals · market value about $2.8M · revenue $3.1M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows